The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about many questions as hospitals and blood centers prepare to order the testing. We've put together a FAQ document to clarify what we know today. We will update the document as we get more information on existing questions and as new questions get asked, and will update the blog with the revised FAQ document.
Thanks for your support as we work to rapidly get this testing available to you. You can find the FAQ document here: CTS COVID-19 Questions and Answers
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
This is the first update to the original CTS communication distributed on July 6th. As previously co...
CTS will implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The ...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
Beginning June 1, 2020 all 5 CTS laboratories will being transitioning from the Grifols Procleix Ult...
A new Learning Center website will launch on Monday, March 30, 2020. While the link to the new Learn...